Found: 19
Select item for more details and to access through your institution.
Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 11, p. 918, doi. 10.1002/ajh.22141
- By:
- Publication type:
- Article
Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 737, doi. 10.3390/vaccines9070737
- By:
- Publication type:
- Article
Isolated Limb Perfusion with Melphalan for the Treatment of Intractable Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.
- Published in:
- Acta Haematologica, 2010, v. 123, n. 3, p. 179, doi. 10.1159/000294963
- By:
- Publication type:
- Article
A Novel High Throughput Process for Generation and Characterization of Chimeric Antigen Receptor (CAR) T Cells.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S381, doi. 10.1016/j.clml.2017.07.229
- By:
- Publication type:
- Article
Chimeric Antigen Receptor ( CAR) therapy for multiple myeloma.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 5, p. 685, doi. 10.1111/bjh.13889
- By:
- Publication type:
- Article
Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 752, doi. 10.1111/bjh.13762
- By:
- Publication type:
- Article
Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma.
- Published in:
- Journal of Translational Medicine, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12967-015-0562-5
- By:
- Publication type:
- Article
Deep dissection of the antiviral immune profile of patients with COVID-19.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02852-1
- By:
- Publication type:
- Article
Longitudinal Analysis of Tetanus- and Influenza-Specific IgG Antibodies in Myeloma Patients.
- Published in:
- Clinical & Developmental Immunology, 2012, p. 1, doi. 10.1155/2012/134081
- By:
- Publication type:
- Article
Patients with Multiple Myeloma Develop SOX2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation.
- Published in:
- Clinical & Developmental Immunology, 2011, p. 1, doi. 10.1155/2011/302145
- By:
- Publication type:
- Article
Prognostic and Diagnostic Value of Spontaneous Tumor-Related Antibodies.
- Published in:
- Clinical & Developmental Immunology, 2010, p. 1, doi. 10.1155/2010/721531
- By:
- Publication type:
- Article
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-023-03619-9
- By:
- Publication type:
- Article
Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 11, p. 1151, doi. 10.1007/s00262-014-1588-x
- By:
- Publication type:
- Article
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14619-z
- By:
- Publication type:
- Article
Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 705, p. 1, doi. 10.1126/scitranslmed.add7900
- By:
- Publication type:
- Article
5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity.
- Published in:
- Mediators of Inflammation, 2014, v. 2014, p. 1, doi. 10.1155/2014/418292
- By:
- Publication type:
- Article
Current Strategies for the Immunotherapy of Multiple Myeloma.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 1, p. 55
- By:
- Publication type:
- Article
Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 5, p. 1142, doi. 10.1002/ijc.28752
- By:
- Publication type:
- Article
NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer.
- Published in:
- International Journal of Cancer, 2010, v. 127, n. 2, p. 381, doi. 10.1002/ijc.25058
- By:
- Publication type:
- Article